IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Therapeutics PUB LTD

CUSIP: G16411810 | 1 institutional holders

Quarters

Q2 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Ikarian Capital, LLC37,641
0.0% of portfolio›$2.1K
StyleTurnoverLocationFiled
Ikarian Capital, LLC
37,641$2.1K0.0%Deep ValueVery HighDallas, TX2020-08-14